post-stroke. We chose to give the protein injection on day 7 post-stroke since there are
not yet many phagocytic cells in the thalamus at that time point60 . The stereotaxic surgery was performed under isoflurane anesthesia (4.5% during
induction, 2.5% during maintenance). After placing the animal in a stereotaxic frame
(Stoelting, Wood Dale, IL, USA), the skull was exposed and a small hole was made with a
dental drill. Using coordinates according to The Rat Brain in Stereotaxic Coordinates61 , 4 µl of vehicle (phosphate buffered saline; PBS), rhCDNF (2.5 µg/µl) or rhMANF
(2.5 µg/µl) was injected into the right thalamus (A/P –3.0; M/L –3.0; D/V –6.0) at speed
0.5 µl/min with 33G blunt needle (Nanofil; World Precision Instruments, Sarasota, FL,
USA). The needle was kept in place for 4 min after the injection to prevent backflow.
RhCDNF and rhMANF (Icosagen, Tartu, Estonia) were produced in a Chinese hamster ovarian
(CHO)-based cell line.
The distribution of rhCDNF in the brain after intra-thalamic injection was tested in
naïve rats by injecting rhCDNF as described above, and sacrificing the animals 2 h after
the stereotaxic injection for immunohistochemistry with anti-hCDNF antibody.